Suchergebnisse - "Zhao, Xiao‐su"

PubPharm (167)

1

A complete oral regimen for induction therapy of patients with high-risk APL : An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy

enthalten in: British journal of haematology | 2024

von Tang, F. | Duan, W. | Liu, X. | +12

2

Targeting TFH cells is a novel approach for donor-specific antibody desensitization of allograft candidates : an in vitro and in vivo study

enthalten in: Haematologica | 2024

von Ma, N. | Wu, W. | Zhao, X. | +11

3

TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML) : results from a comprehensive analysis of 502 AML cases and the Beat AML public database

enthalten in: Clinical and experimental medicine | 2024

von Pan, X. | Chang, Y. | Ruan, G. | +5

4

TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database

enthalten in: Clinical and experimental medicine | 2024

von Pan, X. | Chang, Y. | Ruan, G. | +5

5

ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia

enthalten in: Hematological oncology | 2024

von Shi, Z. | Wang, X. | Chen, W. | +9

6

The impact of donor-specific anti-HLA antibody levels on primary poor graft function and graft rejection in rituximab desensitized haploidentical stem cell transplantation

enthalten in: HLA | 2024

von Liu, J. | Zhao, X. | Xu, L. | +9

7

ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia

enthalten in: Hematological Oncology | 2024

von Shi, Z. | Wang, X. | Chen, W. | +9

8

The impact of donor‐specific anti‐ HLA antibody levels on primary poor graft function and graft rejection in rituximab desensitized haploidentical stem cell transplantation

enthalten in: HLA | 2024

von Liu, J. | Zhao, X. | Xu, L. | +9

9

CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia

enthalten in: Biomolecules & biomedicine | 2023

von Cao, L. | Zhou, Y. | Gale, R. | +14

10

Outcome and molecular measurable residual disease monitoring in adult B-cell acute lymphoblastic leukemia patients with MEF2D fusions

enthalten in: Hematological oncology | 2023

von Sun, K. | Chen, W. | Wang, X. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]